IperionX (IPX) Expected to Post Earnings on Wednesday

IperionX (NASDAQ:IPXGet Free Report) is expected to post its H2 2026 results before the market opens on Wednesday, September 23rd. Analysts expect IperionX to post earnings of ($0.0725) per share and revenue of $1.4930 million for the quarter. Parties may visit the the company’s upcoming H2 2026 earning results page for the latest details on the call scheduled for Tuesday, September 29, 2026 at 7:00 PM ET.

IperionX Trading Up 1.0%

IPX stock opened at $21.05 on Tuesday. The business has a 50-day simple moving average of $22.17 and a 200 day simple moving average of $29.27. IperionX has a 52 week low of $17.40 and a 52 week high of $61.45. The company has a quick ratio of 4.00, a current ratio of 4.03 and a debt-to-equity ratio of 0.03.

Insider Buying and Selling

In other news, CEO Anastasios Arima acquired 138,720 shares of the business’s stock in a transaction that occurred on Friday, July 10th. The shares were bought at an average price of $3.58 per share, with a total value of $496,617.60. Following the acquisition, the chief executive officer directly owned 12,455,502 shares in the company, valued at $44,590,697.16. The trade was a 1.13% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Chairman Todd Hannigan acquired 300,000 shares of IperionX stock in a transaction that occurred on Monday, July 13th. The shares were purchased at an average price of $3.59 per share, for a total transaction of $1,077,000.00. Following the transaction, the chairman directly owned 26,633,334 shares in the company, valued at $95,613,669.06. The trade was a 1.14% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired 663,720 shares of company stock worth $2,379,118 in the last 90 days.

Analysts Set New Price Targets

Several equities analysts have commented on IPX shares. BTIG Research raised their target price on shares of IperionX from $40.00 to $55.00 and gave the company a “buy” rating in a report on Friday, June 5th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of IperionX in a report on Friday, July 17th. Roth Capital set a $53.00 price target on shares of IperionX in a research report on Wednesday, August 5th. Finally, Jefferies Financial Group assumed coverage on shares of IperionX in a research note on Wednesday, September 2nd. They issued a “buy” rating and a $26.00 price objective on the stock. Six equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, IperionX presently has an average rating of “Moderate Buy” and an average target price of $46.50.

Check Out Our Latest Report on IperionX

IperionX Company Profile

(Get Free Report)

IperionX Limited (NASDAQ: IPX) is a materials technology company focused on developing a low-carbon, fully integrated titanium supply chain in the United States. The company is working to produce titanium metal and titanium products from locally sourced mineral resources, with applications across the aerospace, defense, automotive, medical and consumer industries.

IperionX’s flagship asset is the Titan Project in Tennessee, which contains titanium, rare earth and zircon-rich mineral sands.

Recommended Stories

Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.